538 - Predictors of residual metabolic activity on FDG PET/CT in patients treated for pulmonary tuberculosis (ID 361) - Society of Nuclear Medicine and Molecular Imaging 2020 Annual Meeting

538 - Predictors of residual metabolic activity on FDG PET/CT in patients treated for pulmonary tuberculosis (ID 361)

General Clinical Specialties -> Outcomes/Infections Disease/Pulmonary 538

538 - Predictors of residual metabolic activity on FDG PET/CT in patients treated for pulmonary tuberculosis (ID 361)

Session Name

Infection/Pulmonary/Outcomes

Speakers

I. Lawal

Authors

Presentation Topic

General Clinical Specialties -> Outcomes/Infections Disease/Pulmonary

Presentation Number

538

Previous Eposter

537 - Granzyme B PET imaging for assessment of disease activity in inflammatory bowel disease (ID 358)

Next Eposters

540 - Imaging viral load and T cell activation in HIV: Tools for cure development (ID 360)

541 - Labeled leukocyte Imaging: Improved Leukocyte Isolation with a Novel Automated Microfluidics-Based System (ID 364)

543 - ¹⁸F-FDG PET/CTand Radiolabeled Leukocyte Scintigraphy for the Diagnosis of Infected Aortic Aneurysms: a retrospective study (ID 362)

544 - ⁶⁸Ga-FAPI PET/CT for imaging of fibrosis in IgG4-related disease: comparison to ¹⁸F-FDG PET/CT (ID 359)

545 - First-in-human total-body PET imaging of HIV with ⁸⁹Zr-VRC01 on the EXPLORER (ID 357)

546 - HER3 as a Predictor of Response to Neoadjuvant Therapy in Breast Cancer patients. A Clinical Study (ID 839)

547 - Kinetic modeling of [¹⁸F]FES PET in patients with metastatic ER+ breast cancer (ID 840)

550 - Prognostic values of quantitative and morphological parameters of dbPET in patients with luminal-type breast cancer: A pilot study (ID 843)

551 - Reproducibility of uptake on dedicated breast PET and its diagnostic impact (ID 844)

554 - F-18 FDG PET/MRI IN PRIMARY STAGING OF BREAST CANCER: THE RELATIONSHIPS BETWEEN IMAGING PARAMETERS OF PRIMARY TUMOR AND DISTANT METASTASES (ID 845)